Direct compression of highly used excipients in pharmaceutical tablet manufacturing: calcium phosphate dibasic anhydrous and microcrystalline cellulose

Project Details

Short titleMCC & CaHPO4
StatusActive
Effective start/end date1/08/2331/07/27

Collaborative partners

  • Rīga Stradiņš University (lead)
  • Biofarm Sp. o.o.
  • Asahi Kasei Europe GmbH
  • Darnitsa Pharmaceutical Firm
  • MEDELPHARM S.A.S
  • Medical University of Gdańsk
  • Chemische Fabrik Budenheim KG
  • Physiolution Polska sp z o. o.
  • Poznań University of Medical Sciences

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 4 - Quality Education
  • SDG 9 - Industry, Innovation, and Infrastructure

Keywords

  • tablets
  • calcium phosphate dibasic anhydrous
  • CaHPO4
  • microcrystalline cellulose
  • MCC
  • tableting
  • compression
  • compaction
  • punch peak force
  • compression thickness
  • dwell time
  • compression time
  • relaxation time
  • ejection force
  • ejection time
  • rearrangement energy
  • plastic energy
  • compression energy
  • elastic energy
  • flow energy
  • ejection energy
  • tablet weight
  • tablet thickness
  • elastic recovery
  • ejected tablet diameter
  • solid fraction
  • hardness
  • tensile strength

Field of Science

  • 2.5 Materials engineering
  • 2.4 Chemical engineering
  • 1.4 Chemical sciences
  • 1.3 Physical sciences
  • 3.3 Health sciences

Smart Specialization Area

  • Smart materials, technology and engineering

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.